>>HomeContemporary issues



Aktuelle TZDOnews

Contemporary issues

Side 1/13

128 Entries

Side:

23.01.2014

Protagen Protein Services GmbH announced its merger with PANATecs GmbH
Protagen Protein Services (PPS) is a world leading CRO in protein analytics and its application to GMP-compliant characterization of protein therapeutics.   [more]

sciFLEXARRAYER SX_closed.jpg

21.11.2013

SCIENION’s sciFLEXARRAYER Awarded with Product Technology Innovation Award by Materials Science Society AVS
Dortmund and Berlin, Germany: SCIENION AG announced that AVS, a professional society dedicated to the science and technology of materials, interfaces and processing, has awarded SCIENION’s sciFLEXARRAYER dispenser with a Product Technology Innovation Award. Candidates for the award had been selected at the AVS 60th International Symposium and Exhibition in Long Beach CA, USA, October 28-31, 2013.  [more]

ldc_ampullen.jpg

04.11.2013

Lead Discovery Center GmbH announces five-year strategic partnership with Merck Serono
LDC, located in the BioMedizinZentrumDortmund, announced a five-year strategic partnership with Merck Serono, Darmstadt, Germany, the biopharmaceutical division of Merck. This collaboration integrates the expertise and resources of both organizations to expedite the discovery of promising lead structures and to optimize the development of therapeutic candidates in areas of high unmet medical need.  [more]

microarray%20biochip-group-instrumentation-03.jpg

10.09.2013

Scienion technology from Dortmund used for multiparameter testing to enable biohazard detection in water
SCIENION AG announced milestone advancements in the EU MicroAqua research project, which is dedicated to developing a universal microarray for the evaluation of fresh-water quality.  [more]

Nanohale Lab WAZ Bild.jpg

16.12.2011

Nanohale AG to be listed on Frankfurt Stock Exchange as of December 20
“By way of this exchange listing, we aim to strengthen perceptions of our company, particularly in the context of establishing further strategic partnerships in Germany and elsewhere,” said Dr. Nicolas Combé, CFO of Nanohale AG, in explaining the motivations for the listing.   [more]

Müllner.JPG

23.03.2011

instrAction and Protagen from strategic Alliance
instrAction GmbH, Ludwigshafen, the specialist for design and production of selective separation matrices and Protagen AG, Dortmund, a GMP certified service laboratory for protein analysis signed a strategic alliance for the development of customized instrAction® Phases for downstream processing of biotherapeutics.  [more]

Scienion_ head w 8PDCs sciFLEXARRAYER_2.jpg

21.02.2011

Euroimmun to use Scienion Arrayer for Biochip Development and Production
Scienion AG announced on February 21, 2011 that EUROIMMUN AG - one of the leading manufacturers of immuno-biochemical assays - has purchased Scienion`s sciFLEXARRAYER technology to develop multiplexed diagnostic products and to produce new test formats.  [more]

25.08.2009

InterMed Discovery aquires sustainable source for Omega-3 Fatty Acid
InterMed Discovery (IMD), a word class natural product lead-discovery company - based in the BioMedizinZentrumDortmund, anounced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland. This innovative microbial source has the potential to produce Omega-3 more sustainable and reliably compared to established sources.  [more]

protagen bi tester.jpg

12.06.2009

Protagen and OncoTyrol form strategic alliance to validate the UNIarray® technology platform
Dortmund, Germany and New Jersey, USA, June 10, 2009. Protagen AG and the Medical University Innsbruck, Department of Urology, have recently identified autoantigen candidates present in serum of patients with prostate cancer using the proprietary UNIArray® technology platform. In Europe, prostate cancer is the second most frequent lethal malignancy in men. Yearly about 40,000 men die of prostate cancer in the European Union.   [more]

djungel bild biotropics.jpg

20.01.2009

InterMed Discovery Closes Equity Transaction Worth €7,44 M with Biotropics Malaysia Berhad
Dortmund, Germany, January 13, 2009 – InterMed Discovery (IMD), an emerging world class natural product lead-discovery company, today announced the close of an equity transaction worth €7.44 million with Biotropics Malaysia Berhad.   [more]

Side 1/13

128 Entries

Side:



Events

Training events and business breakfasts are provided to the tenants at frequent intervals. At least twice a month specialists for certain topics – such as lawyers, consultants or business economists – are invited in order to give qualified information to the mostly technical orientated young companies.

The full range of events you only find on the  German site.

This is just one of the services which our satisfied tenants profit from.